PC
Polar Capital Portfolio holdings
AUM
$13.5B
1-Year Return
55.85%
This Quarter Return
-13.7%
1 Year Return
+55.85%
3 Year Return
+125.38%
5 Year Return
+259.12%
10 Year Return
–
AUM
$9.35B
AUM Growth
-$2.4B
(-20%)
Cap. Flow
-$758M
Cap. Flow
% of AUM
-8.11%
Top 10 Holdings %
Top 10 Hldgs %
23.17%
Holding
296
New
31
Increased
109
Reduced
93
Closed
43
Top Buys
| 1 |
Danaher
DHR
|
$66.9M |
| 2 |
Berkshire Hathaway Class B
BRK.B
|
$61M |
| 3 |
Thermo Fisher Scientific
TMO
|
$51.3M |
| 4 |
Boston Scientific
BSX
|
$44.2M |
| 5 |
Arista Networks
ANET
|
$43.1M |
Top Sells
| 1 |
Merck
MRK
|
$115M |
| 2 |
Amgen
AMGN
|
$102M |
| 3 |
Apple
AAPL
|
$82.8M |
| 4 |
ATVI
Activision Blizzard Inc.
ATVI
|
$72.8M |
| 5 |
Flex
FLEX
|
$70.4M |
Sector Composition
| 1 | Technology | 25.49% |
| 2 | Financials | 23.49% |
| 3 | Healthcare | 21.31% |
| 4 | Communication Services | 7.67% |
| 5 | Consumer Discretionary | 6.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
DESP
226
DELISTED
Despegar.com
DESP
| $1.4M | 0.02% |
113,097
| – | – |
|
|
MIXT
227
DELISTED
MIX TELEMATICS LIMITED
MIXT
| $1.14M | 0.01% |
72,786
-101,168
| -58% | -$1.58M |
|
|
MTLS
228
Materialise
MTLS
$292M
| $1.1M | 0.01% |
55,107
-165,898
| -75% | -$3.32M |
|
|
VRNA
229
Verona Pharma
VRNA
$9.2B
| $965K | 0.01% |
100,000
| – | – |
|
|
IMMP
230
Immutep
IMMP
$242M
| $920K | 0.01% |
500,000
+254,302
| +104% | +$468K |
|
|
VIVE
231
DELISTED
VIVEVE MED INC
VIVE
| $748K | 0.01% |
712
-186
| -21% | -$195K |
|
|
JOBS
232
DELISTED
51job, Inc.
JOBS
| $723K | 0.01% |
11,572
+619
| +6% | +$38.7K |
|
233
Esquire Financial Holdings
ESQ
$828M
| $653K | 0.01% |
30,085
-6,095
| -17% | -$132K |
|
|
VNET
234
VNET Group
VNET
$2.13B
| $611K | 0.01% |
70,667
+1,882
| +3% | +$16.3K |
|
235
NetEase
NTES
$85B
| $610K | 0.01% |
12,970
+6,760
| +109% | +$318K |
|
|
FENG
236
Phoenix New Media
FENG
$27.7M
| $605K | 0.01% |
31,486
+8,106
| +35% | +$156K |
|
237
NovaGold Resources
NG
$2.75B
| $501K | 0.01% |
126,946
| – | – |
|
238
Summit Therapeutics
SMMT
$19.3B
| $403K | ﹤0.01% |
350,000
| – | – |
|
239
Texas Capital Bancshares
TCBI
$3.96B
| $310K | ﹤0.01% |
+6,065
| New | +$310K |
|
240
Enterprise Financial Services Corp
EFSC
$2.24B
| $297K | ﹤0.01% |
7,884
-1,787
| -18% | -$67.3K |
|
241
Goldman Sachs
GS
$223B
| $273K | ﹤0.01% |
1,637
-1,802
| -52% | -$301K |
|
|
ATVI
242
DELISTED
Activision Blizzard Inc.
ATVI
| – | – |
-874,860
| Closed | -$72.8M |
|
|
RHT
243
DELISTED
Red Hat Inc
RHT
| – | – |
-249,451
| Closed | -$34M |
|
244
Agilent Technologies
A
$36.5B
| – | – |
-778,000
| Closed | -$54.9M |
|
245
Aclaris Therapeutics
ACRS
$227M
| – | – |
-1,443,920
| Closed | -$21M |
|
246
Analog Devices
ADI
$122B
| – | – |
-27,688
| Closed | -$2.56M |
|
|
AMRN
247
Amarin Corp
AMRN
$317M
| – | – |
-69,589
| Closed | -$22.6M |
|
248
Ascendis Pharma
ASND
$12.5B
| – | – |
-50,000
| Closed | -$3.54M |
|
249
Atara Biotherapeutics
ATRA
$90.7M
| – | – |
-4,000
| Closed | -$4.14M |
|
|
AUTL
250
Autolus Therapeutics
AUTL
$389M
| – | – |
-50,000
| Closed | -$1.53M |
|